|
| 35147241 | Cost-effectiveness of second-line therapies in adults with chronic immune thrombocytopenia. | Am J Hematol | 2023 |
| 37640450 | 2023 ACR/EULAR antiphospholipid syndrome classification criteria. | Ann Rheum Dis | 2023 |
| 35476017 | Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support. | Blood Adv | 2023 |
| 35502988 | Sex differences in long-term outcomes of patients with deep vein thrombosis. | Vascular | 2023 |
| 37166332 | Impact of Prophylactic Antibacterials on Coagulation Profiles and Bleeding in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome. | Acta Haematol | 2023 |
| 36920760 | Case 8-2023: A 71-Year-Old Woman with Refractory Hemolytic Anemia. | N Engl J Med | 2023 |
| 36930800 | Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency. | Blood Adv | 2023 |
| 36929442 | Summiting thrombotic hazards in glioma. | Blood | 2023 |
| 34727173 | American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. | Blood Adv | 2022 |
| 37502132 | A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences. | Nat Cardiovasc Res | 2022 |
| 35503027 | American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients. | Blood Adv | 2022 |
| 35500590 | The case for classical haematology: the impact of a name and the future of a field. | Lancet Haematol | 2022 |
| 35748885 | American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. | Blood Adv | 2022 |
| 36494152 | COVID-19 and antiphospholipid antibodies. | Best Pract Res Clin Haematol | 2022 |
| 36485139 | Thrombosis questions from the inpatient wards. | Hematology Am Soc Hematol Educ Program | 2022 |
| 36108253 | Bias Against International Medical Graduates in the Hematology/Oncology Fellowship Recruitment Process: Findings From a Nationwide Survey of Fellowship Program Directors. | JCO Oncol Pract | 2022 |
| 35871468 | Association of iron infusion reactions with ABO blood type. | Eur J Haematol | 2022 |
| 35984499 | Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluation. | Ann Hematol | 2022 |
| 35015586 | Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors. | JCO Oncol Pract | 2022 |
| 35051831 | Clinical characteristics, time course, and outcomes of major bleeding according to bleeding site in patients with venous thromboembolism. | Thromb Res | 2022 |
| 34990292 | Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment. | JCO Oncol Pract | 2022 |
| 35259186 | Association of renalase with clinical outcomes in hospitalized patients with COVID-19. | PLoS One | 2022 |
| 34587251 | SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. | Blood | 2022 |
| 33469595 | Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis. | medRxiv | 2021 |
| 33655244 | Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. | bioRxiv | 2021 |
| 33765243 | Clinical characteristics and outcomes of splenic infarction in cancer patients: a retrospective, single center report of 206 cases. | J Thromb Thrombolysis | 2021 |
| 33564789 | Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC). | medRxiv | 2021 |
| 33537523 | Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID-19. | Res Pract Thromb Haemost | 2021 |
| 33560401 | American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. | Blood Adv | 2021 |
| 33894166 | Accurate accounting of caplacizumab cost effectiveness. | Lancet Haematol | 2021 |
| 33635335 | A neutrophil activation signature predicts critical illness and mortality in COVID-19. | Blood Adv | 2021 |
| 34474482 | American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. | Blood Adv | 2021 |
| 34506735 | Hospitalisation among vaccine breakthrough COVID-19 infections. | Lancet Infect Dis | 2021 |
| 33991637 | Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy. | J Hepatol | 2021 |
| 33966492 | Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients. | Stroke | 2021 |
| 34145437 | Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19. | Nat Med | 2021 |
| 34114208 | Immunothrombosis: a COVID-19 concerto. | Br J Haematol | 2021 |
| 34370974 | Cerebral venous sinus thrombosis after vaccination: the UK experience. | Lancet | 2021 |
| 34111030 | Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection. | JCI Insight | 2021 |
| 34281793 | Association of obesity with venous thromboembolism and myocardial injury in COVID-19. | Obes Res Clin Pract | 2021 |
| 34192434 | A Brewing Back Pain. | N Engl J Med | 2021 |
| 34358229 | Challenges in interpreting cytokine data in COVID-19 affect patient care and management. | PLoS Biol | 2021 |
| 33280030 | Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. | Blood | 2021 |
| 33214651 | Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. | Nat Rev Cardiol | 2021 |
| 33476420 | Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis. | Am J Hematol | 2021 |
| 31190408 | Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis. | J Eval Clin Pract | 2020 |
| 32045473 | Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura. | Blood Adv | 2020 |
| 33282193 | Circulating markers of angiogenesis and endotheliopathy in COVID-19. | Pulm Circ | 2020 |
| 33398292 | Changes in inflammatory and immune drivers in response to immunomodulatory therapies in COVID-19. | medRxiv | 2020 |
| 33269995 | Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state. | Hematology | 2020 |